Recent guidelines for non-alcoholic fatty liver disease (NAFLD)/ fatty liver disease (FLD): are they already outdated and in need of supplementation
A protocol for a randomised, double-blind, placebo-controlled study of the effect of LIraglutide on left VEntricular function in chronic heart failure patients with and without type 2 diabetes (The LIVE Study)
In men with obesity-related functional hypogonadism, excess fat tissue can increase aromatase activity, converting more testosterone into estradiol, while inflammation and insulin resistance further suppress the HPG axis
The abdomen typically has higher blood flow and a denser concentration of nerve endings near the surface, which can lead to faster absorption and more immediate sensitivity
Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)
Clinical research consistently positions Ozempic as one of the most effective GLP-1 medications available for weight management